POLISCOPE
Back to feed
FEDERALhearing transcript
High Impact

Congressional Hearing: The Business Model Behind the Fentanyl Crisis

Original title: FOLLOW THE MONEY: THE CCP'S BUSINESS MODEL FUELING THE FENTANYL CRISIS

January 1, 2023

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing examines the financial infrastructure and international supply chains that facilitate the illegal importation of fentanyl, which directly impacts U.S. public health and law enforcement strategies.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Law Enforcement Agencies

Local and federal agencies provided testimony and statements regarding the operational challenges of tracking illicit financial flows related to drug trafficking.

U.S. Residents

The hearing addresses the supply chain of fentanyl, which impacts public health and safety in communities across the country.

What changed

Last recorded activity January 1, 2023.

What's next

Next step not available in the current record.

Summary

This document is the official record of a March 23, 2023, House hearing investigating how financial systems and business practices in China contribute to the flow of fentanyl into the United States. The hearing featured testimony from former law enforcement officials and policy experts regarding the illicit financial networks supporting drug trafficking.

Key Facts

  • The hearing was held on March 23, 2023, by the House Subcommittee on National Security, Illicit Finance, and International Financial Institutions.
  • The primary focus was the business model and financial networks linked to the Chinese Communist Party (CCP) that facilitate the fentanyl trade.
  • Five expert witnesses provided testimony, including former officials from the U.S. Treasury and the DEA.
  • The record includes extensive supplemental materials, including statements from various sheriff's departments and policy institutes regarding fentanyl trafficking.
  • The hearing record is documented as Serial No. 118-11 of the 118th Congress.

Frequently Asked Questions

What was the purpose of this hearing?
To investigate the financial business models and international networks that enable the production and distribution of fentanyl from China into the United States.
Who testified at the hearing?
The witnesses included John A. Cassara (retired Treasury Special Agent), Jason Grellner (Evolv Technology), Donald H. Im (retired DEA Assistant Special Agent), Gretchen Peters (Alliance to Counter Crime Online), and Celina B. Realuyo (George Washington University).

Why It Matters

The hearing examines the financial infrastructure and international supply chains that facilitate the illegal importation of fentanyl, which directly impacts U.S. public health and law enforcement strategies.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

cross reference100% confidence

Extensive Supplemental Record

The hearing record contains a significant volume of external reports and statements from law enforcement, indicating a coordinated effort to document the local impact of international drug trafficking.

Connected Entities

personGretchen PetersExecutive Director of the Alliance to Counter Crime Online and hearing witness.Map →
personJohn A. CassaraRetired U.S. Treasury Special Agent and hearing witness.Map →
personDonald H. ImRetired DEA Assistant Special Agent in Charge and hearing witness.Map →
personBlaine LuetkemeyerChairman of the Subcommittee.Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance85
    How much this matters to a regular citizen
  • Controversy60
    Intensity of disagreement among stakeholders
  • Entertainment20
    Compellingness for a non-policy-wonk reader
  • Buzz40
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record